Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Estrogen Receptor beta ELISA Kit (AC3613)
Cat.#: ASET-2202
Specifications
Description Human Estrogen Receptor beta ELISA Kit allows for the in vitro quantitative determination of human Estrogen Receptor beta concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1339 Human YWHAE ELISA Kit (AC2750) Quantitative inquiry ASET-2405 Human Neuritin ELISA Kit (AC3816) Quantitative inquiry ASET-1471 Mouse GSK3 beta ELISA Kit (AC2882) Quantitative inquiry ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-1523 Human Glicentin ELISA Kit (AC2934) Quantitative inquiry ASET-1073 Human FGFR4 ELISA Kit (AC2484) Quantitative inquiry ASET-2012 Human GIRK2 ELISA Kit (AC3423) Quantitative inquiry ASET-2399 Human PITPNC1 ELISA Kit (AC3810) Quantitative inquiry ASET-1925 Human MERTK ELISA Kit (AC3336) Quantitative inquiry ASET-2270 Human Insulin ELISA Kit (AC3681) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket